Aspreva's plan of arrangement with Galenica completed(01/07/2008) Aspreva Pharmaceuticals Corporation announced the completion of the plan of arrangement with Galenica Group, pursuant to which Galenica, through a wholly-owned Canadian subsidiary, acquired all outstanding shares of Aspreva for US$26.00 per share in ...